Acrisure Appoints New Leaders in Technology and Administration
April 8, 2025 - 10:03
Acrisure LLC has announced significant leadership changes, appointing Mark Wassersug as the new Chief Technology Officer and Shawn Pelsinger as Chief Administrative Officer. Wassersug, who previously held a prominent position at Intercontinental Exchange Inc., brings a wealth of experience in technology and innovation to Acrisure. His expertise is expected to drive the company's technological advancements and enhance its digital offerings.
Meanwhile, Pelsinger joins Acrisure from Palantir Technologies Inc., where he played a crucial role in administrative functions. His background in managing complex operations will be instrumental as Acrisure seeks to streamline its administrative processes and improve overall efficiency.
These strategic appointments reflect Acrisure's commitment to strengthening its leadership team in order to navigate the rapidly evolving landscape of the financial services industry. The company aims to leverage the skills and experiences of its new executives to foster growth and drive innovation in the coming years.
MORE NEWS
May 4, 2026 - 02:04
Archaeologists recreate Pompeii victim using AI technologyA team of archaeologists has turned to artificial intelligence to reconstruct the face of a man who died in the eruption of Mount Vesuvius nearly 2,000 years ago. The victim, whose remains were...
May 3, 2026 - 10:57
Risk, Resilience, And Humanity's Expanding Technological FrontiersAs humanity barrels toward what experts call the Convergence Age, the lines between the physical world, digital networks, and biological systems are dissolving. We are no longer just users of...
May 2, 2026 - 20:16
Business Leaders Say Adapting to AI Is Essential to SurvivalTop executives from IBM, VaynerX, and Deepblocks recently spoke to the TIME100 community about the relentless speed of change that artificial intelligence is forcing upon every industry. The...
May 2, 2026 - 02:14
A brain implant to treat depression gets FDA greenlight to start trialsA small medical device company has received permission from the U.S. Food and Drug Administration to begin testing a brain implant designed to treat depression. Motif Neurotech, the Texas-based...